Checkpoint-Inhibitors Archive | IOZK

Safety of nivolumab in combination with dendritic cell vaccines in recurrent high-grade glioma.

2019-06-17/in Checkpoint-Inhibitors, Dendritic Cells, Glioblastoma, International Publications /von 2019-06-17 / J Clin Oncol 37, 2019 (suppl; abstr e13526)

On the Other Side: Manipulating the Immune Checkpoint Landscape of Dendritic Cells to Enhance Cancer Immunotherapy

2019-02-06/in Checkpoint-Inhibitors, Dendritic Cells, International Publications /von 2019-02-06 / Front Oncol 2019;9:50

Effective Immunotherapy of Glioblastoma in an Adolescent with Constitutional Mismatch Repair-Deficiency Syndrome

2019-01-01/in Checkpoint-Inhibitors, Dendritic Cells, Glioblastoma, International Publications /von 2019-01-01 / Klin Onkol 2019;32(1):70-74

Combination Strategies to Optimize Efficacy of Dendritic Cell-Based Immunotherapy

2018-12-05/in Checkpoint-Inhibitors, Dendritic Cells, International Publications /von 2018-12-05 / Front Immunol 2018;9:2759

Dendritic Cell Cancer Therapy: Vaccinating the Right Patient at the Right Time

2018-10-01/in Checkpoint-Inhibitors, Dendritic Cells, International Publications /von 2018-10-01 / Front Immunol 2018;9:2265

Complete Clinical Remission of Stage IV Triple-Negative Breast Cancer Lung Metastasis Administering Low-Dose Immune Checkpoint Blockade in Combination With Hyperthermia and Interleukin-2

2018-09-07/in Breast Cancer, Checkpoint-Inhibitors, Hyperthermia, International Publications /von 2018-09-07 / Integr Cancer Ther 2018 12;17(4):1297-1303

Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4 T-lymphocyte counts

2018-08-29/in Checkpoint-Inhibitors, Dendritic Cells, Glioblastoma, International Publications /von 2018-08-29 / CNS Oncol 2018 07;7(3):CNS22

Combining vaccines and immune checkpoint inhibitors to prime, expand, and facilitate effective tumor immunotherapy

2018-08-22/in Checkpoint-Inhibitors, International Publications /von 2018-08-22 / Expert Rev Vaccines 2018 08;17(8):697-705

Lysis-independent potentiation of immune checkpoint blockade by oncolytic virus

2018-06-19/in Checkpoint-Inhibitors, International Publications, Newcastle Disease Virus /von 2018-06-19 / Oncotarget 2018 Jun;9(47):28702-28716

PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy

2018-03-05/in Checkpoint-Inhibitors, International Publications, Newcastle Disease Virus /von 2018-03-05 / J. Clin. Invest. 2018 Apr;128(4):1413-1428